Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MANBA | O00462 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | SLC5A2 | P31639 | 8/20 | 0.35 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.33 |
| ▸ | AGL | P35573 | 1/20 | 0.33 |
| ▸ | OGA | O60502 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15266072 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL7432236 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL15265936 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL3069911 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL9880695 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL4172279 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL15265566 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL10075956 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL22090238 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 | |
| SCHEMBL9880689 | 1.00 | MANBA (0.44) | MANBALMNATHRBHIF1ASLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651864-A2 | E3 LIGASE FAMILY FUNCTIONS AND INTERACTIONS | GENENTECH, INC. (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250186345-A1 | PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE | GLYCOMINE, INC. (US) | 2025-06-12 | — | — | US | claimed |
| EP-4563152-A2 | PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE | Glycomine, Inc. (US) | 2025-06-04 | — | — | EP | claimed |
| US-12303541-B2 | Erodium crassifolium L'Her plant extracts and uses thereof | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER) (IL) | 2025-05-20 | — | — | US | claimed |
| US-20250043349-A1 | DEORPHANIZING ODORS USING SINGLE CELL SEQUENCING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-02-06 | — | — | US | claimed |
| CN-119032793-A | Cultivation method of artificial cordyceps sobolifera, furan type galactomannan, preparation method and application thereof | 浙江省林业科学研究院 | 2024-11-29 | — | — | CN | claimed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | claimed |
| WO-2024155901-A2 | E3 LIGASE FAMILY FUNCTIONS AND INTERACTIONS | GENENTECH, INC. (US) | 2024-07-25 | — | — | WO | claimed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | claimed |
| WO-2023195929-A2 | BENCH-STABLE SULFONES AS GLYCOSYL DONORS FOR CARBOHYDRATE SYNTHESIS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-10-12 | — | — | WO | claimed |
| EP-3347413-A1 | POLYOLEFIN COMPOSITIONS | SABIC Global Technologies B.V. (NL) | 2018-07-18 | — | — | EP | claimed |
| WO-2017042092-A1 | POLYOLEFIN COMPOSITIONS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-03-16 | — | — | WO | claimed |
| WO-2005092907-A2 | MONOSACCHARIDE DERIVATIVES AS ANTI-CANCER AND ANTI-INFLAMMATORY AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2005-10-06 | — | — | WO | claimed |
| EP-1506213-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2005-02-16 | — | — | EP | claimed |
| EP-1144425-B1 | DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS | RANBAXY LAB LTD (IN) | 2004-06-16 | — | — | EP | claimed |
| WO-2003097657-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2003-11-27 | — | — | WO | claimed |
| US-6329344-B1 | UREA DERIVATIVE OF ALKYLENE DIOXYFURAN ETHERS | RANBAXY LABORATORIES LIMITED (IN) | 2001-12-11 | — | — | US | claimed |
| EP-1144425-A1 | DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS | RANBAXY LABORATORIES, LTD. (IN) | 2001-10-17 | — | — | EP | claimed |
| WO-2000042053-A1 | DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS | RANBAXY LABORATORIES LIMITED (US) | 2000-07-20 | — | — | WO | claimed |
| EP-0581916-B1 | ANTI-PROLIFERATIVE AND ANTI-INFLAMMATORY COMPOUNDS: 5- OR 6-DEOXY HEXOSE MONOSACCHARIDES HAVING A SATURATED NITROGEN-CONTAINING HETEROCYCLE AT THE 5- OR 6-POSITION BOUND THROUGH THE NITROGEN ATOM | BOSTON LIFE SCIENCES INC (US) | 1998-02-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | MANBA 1165/4885LMNA 4834/4885THRB 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.